The Efficacy of Huaiqihuang Granule in Children With Primary Nephrotic Syndrome
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 1500
Summary
- Conditions
- Nephrotic Syndrome
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 1 years and 18 years
- Gender
- Both males and females
Description
This is a multisite, open-label, prospective and registered study designed to evaluate the efficacy and safety of Huai-Qi-Huang granule in children with primary nephrotic syndrome(PNS). The study will be Planned at 1500 participants, and subjects will be on study for up to one year. Data will be col...
This is a multisite, open-label, prospective and registered study designed to evaluate the efficacy and safety of Huai-Qi-Huang granule in children with primary nephrotic syndrome(PNS). The study will be Planned at 1500 participants, and subjects will be on study for up to one year. Data will be collected by authorized physicians for 48 weeks. all of the data included demographic characteristics, information about PNS, laboratory tests and adverse events.
Tracking Information
- NCT #
- NCT03332420
- Collaborators
- Capital Institute of Pediatrics, China
- Investigators
- Principal Investigator: Chaoying Chen, Professor Children's Hospital of The Capital Institute of Pediatrics
Get Well Soon